Bile Duct Neoplasms: all 220 studies
Page 1 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-METRecruitingNCT07873450Phase 1/2
- Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform StudyNot yet recruitingNCT07729917Phase 2
- TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)Not yet recruitingNCT07653594Not applicable
- Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)RecruitingNCT07558304Not applicable
- A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9RecruitingNCT07186842Phase 1/2
- Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft PancreasRecruitingNCT07155525Not applicable
- Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible AccessoriesRecruitingNCT07120295Phase 4
- A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid TumorsNot yet recruitingNCT07036185Phase 1
- Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar CholangiocarcinomaRecruitingNCT07030140Phase 2
- Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)Not yet recruitingNCT06928415
- On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver CancerRecruitingNCT06877637
- Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsNot yet recruitingNCT06730581Phase 2
- Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
- Spanish Registry of Digestive Tumours RETUDRecruitingNCT06711211
- EUS Examination Using EndoSound Vision System vs. Standard EchoendoscopeRecruitingNCT06340620Not applicable
- Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)RecruitingNCT06277531
- Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract CancerRecruitingNCT06274879Phase 2
- Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsRecruitingNCT06256055Phase 1
- Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct CancerNot yet recruitingNCT06196658Early Phase 1
- Endoscopic Radiofrequency Ablation for Unresectable CholangiocarcinomaRecruitingNCT06175845Not applicable
- A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation ProfilesRecruitingNCT06115655
- Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary CarcinomaEnrolling by invitationNCT06076252Not applicable
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06043466Phase 1
- A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)RecruitingNCT06028724
- Combined Treatment of Treated Bile Duct CancerNot yet recruitingNCT05911425Phase 2
- The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract DiseasesNot yet recruitingNCT05896956
- Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated CholangiocarcinomaRecruitingNCT05874414Phase 1/2
- A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)RecruitingNCT05849480Phase 1/2
- Looking At Bile Duct Cancer Patient Experience Patterns in Medical TrialsNot yet recruitingNCT05706974
- Y-90 With Durvalumab/Gem/Cis in Intrahepatic CholangioRecruitingNCT05655949Phase 2
- Screening Single-operator Cholangioscopy for Neoplastic Bile Duct LesionsRecruitingNCT05600803
- Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic CholangiocarcinomaRecruitingNCT05519319Not applicable
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaRecruitingNCT05286814Phase 2
- PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPIRecruitingNCT05172310Phase 1
- Prognostic Factors in Periampullary Tumors and CystsRecruitingNCT05155878
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsRecruitingNCT05150691Phase 1/2
- Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesRecruitingNCT05000294Phase 1/2
- Liver Transplantation for Non-resectable Perihilar CholangiocarcinomaRecruitingNCT04993131Not applicable
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable
- Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract CancersRecruitingNCT04645160Phase 1/2
- AZD6738 Plus Durvalumab in Biliary Tract CancerRecruitingNCT04298008Phase 2
- Quebec Pancreas Cancer StudyRecruitingNCT04104230
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of CancerRecruitingNCT01915225
- A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsCompletedNCT05712356Phase 2Results posted
- Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension StudyCompletedNCT04924062Phase 3Results posted
- A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid TumorsCompletedNCT04853017Phase 1Results posted
- Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).TerminatedNCT04566133Phase 2Results posted
- Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsTerminatedNCT04383210Phase 2Results posted
- Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic CholangiocarcinomaTerminatedNCT04276090Not applicableResults posted
- Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract CancerCompletedNCT04072445Phase 2Results posted
- Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene MutationsActive, not recruitingNCT04042831Phase 2Results posted
- Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)CompletedNCT04003636Phase 3Results posted
- Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)CompletedNCT03111732Phase 2Results posted
- A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6CompletedNCT03058289Phase 1/2Results posted
- A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)CompletedNCT02821754Phase 2Results posted
- Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversCompletedNCT02349412Phase 3Results posted
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
- Single Agent Regorafenib in Refractory Advanced Biliary CancersCompletedNCT02115542Phase 2Results posted
- Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by SurgeryCompletedNCT02042443Phase 2Results posted
- Cabozantinib (XL-184) Monotherapy for Advanced CholangiocarcinomaCompletedNCT01954745Phase 2Results posted
- CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By SurgeryCompletedNCT01766219Phase 1/2Results posted
- Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic CancerCompletedNCT01534637Phase 2Results posted
- MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryCompletedNCT01425879Phase 2Results posted
- Effects of Preoperative Immunonutrition in Patients Undergoing PancreaticoduodenectomyCompletedNCT01256034Phase 4Results posted
- Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersTerminatedNCT01229111Phase 2Results posted
- Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationTerminatedNCT01151761Phase 2Results posted
- Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary CancersCompletedNCT01134276Not applicableResults posted
- Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT01093222Phase 2Results posted
- Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic TherapyCompletedNCT00919061Phase 2Results posted
- Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
- Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
- S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctCompletedNCT00789958Phase 2Results posted
- CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
- Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By SurgeryCompletedNCT00553332Phase 2Results posted
- Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by SurgeryTerminatedNCT00478140Phase 2Results posted
- Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
- Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary TumorsCompletedNCT00356889Phase 2Results posted
- Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerCompletedNCT00107536Phase 2Results posted
- Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00101036Phase 2Results posted
- Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderTerminatedNCT00085410Phase 2Results posted
- S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00033540Phase 2Results posted
- Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNBCompletedNCT06887023
- The Future Management of Patients With Neoplasms of the Gastro-intestinal TractActive, not recruitingNCT06728358Not applicable
- Outcomes and Prognostic Factors in HepatopancreatoduodenectomyCompletedNCT06631352
- Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal StentsActive, not recruitingNCT06453590Not applicable
- A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsTerminatedNCT06336148Phase 1
- Feasibility of Cryobiopsy from the Bile Duct - CRYLEOCompletedNCT06249841Not applicable
- Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)Active, not recruitingNCT06109779Phase 3
- Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)Active, not recruitingNCT06048133Phase 2
- Effects of Dexamethasone on Common Bile Duct Cannulation TimeCompletedNCT05945797Not applicable
- Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsCompletedNCT05858736Phase 1
- FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination TherapyStatus unknownNCT05662488
- CH-EUS in Diagnosis of Inoperable Bile Duct TumorsStatus unknownNCT05418543Not applicable
- AI Guidance for Biopsy in Suspected CholangiocarcinomaActive, not recruitingNCT05374122Not applicable
- A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid TumorsTerminatedNCT05346484Phase 1
- RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTIONStatus unknownNCT05320328
- Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal CancerActive, not recruitingNCT05277766Phase 1
- Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.CompletedNCT05266300
- Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824